U.S. Leisure Stock News

NasdaqGS:ARM
NasdaqGS:ARMSemiconductor

Assessing Arm Holdings (NasdaqGS:ARM) Valuation After A Powerful Recent Share Price Surge

Recent performance snapshot Arm Holdings (NasdaqGS:ARM) has caught investor attention after a strong recent run, with the stock showing a 48% gain over the past month and 72% over the past 3 months. Those returns add to an 86% move year to date and an 83% total return over the past year. This has prompted closer scrutiny of how current pricing lines up with the company’s fundamentals and growth profile. See our latest analysis for Arm Holdings. At a share price of US$213.33, Arm’s recent...
NasdaqGS:JKHY
NasdaqGS:JKHYDiversified Financial

Why Jack Henry (JKHY) Is Down 5.0% After Raising Full-Year Guidance And Earnings Outlook

In early May 2026, Jack Henry & Associates reported third-quarter fiscal 2026 results showing higher sales of US$636.25 million and increased net income of US$122.89 million, alongside updated full-year guidance calling for up to US$2.53 billion in revenue, operating margins near 25%, and earnings per share between US$6.78 and US$6.87. The company also continued to reshape its capital structure, completing repurchases of over 40% of its shares since 2002, while raising full-year deconversion...
NasdaqGS:LULU
NasdaqGS:LULULuxury

Founder Showdown At Lululemon Puts Governance And Valuation In Focus

Founder Chip Wilson has escalated his public activist campaign against lululemon athletica's leadership and board. Wilson has proposed an alternative slate of directors, criticized the CEO succession process, and issued a direct letter to shareholders. Legal investigations into board conduct and interest from other activist investors are adding pressure ahead of the 2026 Annual Meeting. For investors watching NasdaqGS:LULU, this clash comes after a stretch of weak share performance, with...
NasdaqGM:GCMG
NasdaqGM:GCMGCapital Markets

GCM Grosvenor (GCMG) Margin Improvement To 8.2% Challenges Bearish Earnings Narratives

GCM Grosvenor (GCMG) has wrapped up FY 2025 with fourth quarter revenue of US$176.4 million and basic EPS of US$0.33, alongside trailing 12 month EPS of US$0.87 on revenue of US$554.4 million and earnings growth of 142.7% over the past year. Over the last few quarters, revenue has moved from US$165.1 million in Q4 FY 2024 to US$176.4 million in Q4 FY 2025, while quarterly EPS shifted from US$0.17 to US$0.33 over the same period. This was backed by a trailing 12 month net profit margin of 8.2%...
NYSE:OMF
NYSE:OMFConsumer Finance

Is OneMain Holdings (OMF) Offering Value After Recent Share Price Swings?

If you are wondering whether OneMain Holdings at around US$55.69 is offering genuine value or just looks cheap on the surface, this article will help you size up the stock through a valuation lens. The share price has seen mixed moves recently, with a 5.2% decline over the last week, a 3.5% gain over the past month, and a 19.4% decline year to date. Over longer periods, the 1 year and 3 year returns of 20.1% and 96.9% sit alongside a 64.5% return over 5 years. Recent headlines around OneMain...
NasdaqGS:RUN
NasdaqGS:RUNElectrical

Sunrun (RUN) Valuation Check After Q1 2026 Beat And Storage First Momentum

Sunrun (RUN) is back in focus after reporting Q1 2026 results that topped market expectations, with higher revenue, positive net income and improved margins, alongside commentary reinforcing its storage first, vertically integrated approach. See our latest analysis for Sunrun. The Q1 beat and securitization news have arrived at a time when short term momentum is picking up, with a 1 day share price return of 7.56% and 1 year total shareholder return of 62.35%. However, the 90 day share price...
NYSE:AMCR
NYSE:AMCRPackaging

The Bull Case For Amcor (AMCR) Could Change Following Dividend Hike And Berry Integration Milestones – Learn Why

In early May 2026, Amcor reported third-quarter sales of US$5,914 million, net income of US$278 million, and declared a higher quarterly cash dividend of US$0.65 per share (A$0.91 for ASX CDI holders), reflecting the Board’s confidence in its cash generation and the Berry Global integration. Beyond the headline growth, Amcor’s results underscored how the Berry acquisition is reshaping the business, with substantial synergy capture, portfolio reshaping through divestitures, and even a planned...
NasdaqGS:AMRX
NasdaqGS:AMRXPharmaceuticals

Amneal Pharmaceuticals (AMRX) Profit Rebound Challenges Concerns Over Earnings Quality

Amneal Pharmaceuticals (AMRX) has closed out FY 2025 with fourth quarter revenue of US$814.3 million and basic EPS of US$0.11, alongside trailing twelve month revenue of about US$3.0 billion and basic EPS of US$0.23. Over recent periods the company has seen quarterly revenue move from US$702.5 million in Q3 FY 2024 to US$730.5 million in Q4 FY 2024 and then to US$695.4 million, US$724.5 million, US$784.5 million and US$814.3 million across the four quarters of FY 2025. Basic EPS shifted from...
NYSE:HPE
NYSE:HPETech

Hewlett Packard Enterprise Expands AI Edge And Self Driving Networks Story

Hewlett Packard Enterprise (NYSE:HPE) has introduced fully autonomous self-driving network features across HPE Mist and HPE Aruba Central. The company has also launched rugged, AI-ready edge computing systems, including ProLiant Compute EL2000 and Gen12 servers, for harsh and remote environments. These launches extend HPE's role in enterprise networking, AI inferencing, and mission-critical edge workloads for sectors such as national security, telecoms, and manufacturing. Hewlett Packard...
NYSE:NNI
NYSE:NNIConsumer Finance

Nelnet (NNI) Margin Recovery To 25.6% Challenges Longstanding Bearish Profitability Narratives

Nelnet (NNI) has capped FY 2025 with fourth quarter total revenue of US$341.5 million and basic EPS of US$1.60, alongside trailing 12 month revenue of US$1.7 billion and EPS of US$11.79, set against a one year earnings growth figure of 132.8%. Over recent periods, total revenue has moved from US$373.5 million and EPS of US$1.73 in Q4 FY 2024 to US$516.1 million with EPS of US$4.97 in Q2 FY 2025 and US$435.7 million with EPS of US$2.94 in Q3 FY 2025, illustrating a year in which shifting...
NYSE:IBP
NYSE:IBPConsumer Durables

Installed Building Products (IBP) Valuation Check After Recent Share Price Weakness

Installed Building Products stock: why recent performance has investors watching closely Installed Building Products (IBP) has drawn fresh attention after a stretch of weaker share performance. The stock has shown negative returns over the past week, month and past 3 months, although it still has a positive 1 year total return. See our latest analysis for Installed Building Products. The recent 1 day share price return of a 27.57% decline at a share price of $216.92 continues a pattern of...
NasdaqGM:MAAS
NasdaqGM:MAASInsurance

Is It Too Late To Consider Maase (MAAS) After A 64% Monthly Surge?

Wondering whether Maase at US$9.30 is priced for opportunity or already reflecting expectations? This article walks through what the current valuation suggests about the stock. Over the last month, the share price return of 64.0% and a year-to-date return of 59.7%, despite a 4.1% decline over the past week, indicate that the market's view on the stock has been shifting quickly. Recent coverage around Maase has focused on its positioning within the insurance sector and how investors are...
NasdaqGS:AMBA
NasdaqGS:AMBASemiconductor

A Look At Ambarella (AMBA) Valuation After CEO Fermi Wang’s IEEE Arun N. Netravali Award Recognition

Ambarella (AMBA) is back on investors’ radars after co‑founder, president, and CEO Fermi Wang received the inaugural 2026 IEEE Arun N. Netravali Award, highlighting the company’s work in AI‑powered video technology and edge AI semiconductor platforms. See our latest analysis for Ambarella. The recent award recognition comes as Ambarella’s share price has climbed to US$74.27, with a 30 day share price return of 45.66% and a 1 year total shareholder return of 40.56%. This suggests momentum has...
NasdaqGM:WINA
NasdaqGM:WINASpecialty Retail

Will Winmark’s New Omnichannel Voice Reframe Its Brand and Franchise Strategy Narrative (WINA)?

Winmark Corporation recently announced that long-serving director Lawrence A. Barbetta will not stand for re-election in April 2027, while appointing Casey’s General Stores executive Stephanie S. Hoppe to its Board and key committees, in line with its independent director term-limit policy. This refresh brings fresh marketing and omnichannel retail expertise into Winmark’s boardroom, potentially influencing how the company approaches brand positioning and franchise growth decisions. Next,...
NasdaqCM:WULF
NasdaqCM:WULFSoftware

TeraWulf (WULF) Quarterly Loss Of US$126.6 Million Tests Bullish AI Growth Narratives

TeraWulf FY 2025: Headline Numbers and What They Signal TeraWulf (WULF) has reported FY 2025 results with fourth quarter revenue of US$35.8 million and a basic EPS loss of US$0.30, alongside net income excluding extra items of a US$126.6 million loss. This sets the tone for a year where scale and profitability are clearly still in tension. Over recent quarters, the company has seen revenue move from US$27.1 million in Q3 2024 to US$34.4 million in Q1 2025, US$47.6 million in Q2 2025, US$50.6...
NasdaqGS:LEE
NasdaqGS:LEEMedia

Lee Enterprises (LEE) Q1 Losses Challenge Bullish Narrative Around Low P/S Valuation

Q1 2026 earnings snapshot Lee Enterprises (LEE) opened fiscal 2026 with Q1 revenue of $130.1 million and a basic EPS loss of $0.92, alongside trailing twelve month revenue of $547.8 million and a basic EPS loss of $4.34. Over recent quarters the company has seen revenue move from $144.6 million in Q1 2025 to $130.1 million in Q1 2026. Quarterly basic EPS has ranged from a loss of $2.80 to a loss of $0.31 as net income excluding extra items moved between a loss of $16.7 million and a loss of...
NasdaqGS:BKR
NasdaqGS:BKREnergy Services

Assessing Baker Hughes (BKR) Valuation After Barclays Downgrade And Weaker Crude Price Sentiment

Conference spotlight and stock pressure set the stage Baker Hughes (BKR) heads into its Barclays Americas Select Conference appearance with the stock under pressure after a Barclays downgrade and weaker crude prices linked to expectations of a potential U.S. Iran peace agreement. See our latest analysis for Baker Hughes. Those conference headlines and the Barclays downgrade come after a sharp 7 day share price return of negative 8.8%. The stock still carries a 34.8% year to date share price...
NYSE:OSK
NYSE:OSKMachinery

Oshkosh (OSK) Margin Slippage To 6.2% Tests Bullish Earnings Narratives

Oshkosh (OSK) just wrapped up FY 2025 with Q4 revenue of US$2,688.8 million and basic EPS of US$2.11, supported by trailing twelve month revenue of US$10.4 billion and EPS of US$10.08. The company has seen quarterly revenue move from US$2,598.1 million in Q4 2024 to US$2,688.8 million in Q4 2025, while quarterly EPS shifted from US$2.35 to US$2.11 over the same period. This sets up a picture of steady scale with earnings that investors will be dissecting closely. With a trailing net margin of...
NYSE:XPOF
NYSE:XPOFHospitality

Xponential Fitness (XPOF) Q4 Loss And Ongoing TTM Losses Test Bullish Profitability Narrative

Xponential Fitness (XPOF) closed out FY 2025 with Q4 revenue of US$83.0 million and a basic EPS loss of US$1.17, alongside a trailing twelve month revenue base of US$314.9 million and a TTM basic EPS loss of US$1.47. Over the last six reported quarters, the company has seen quarterly revenue range from US$76.2 million to US$83.2 million while basic EPS losses have moved between US$0.01 and US$1.36. This gives investors a clearer view of how sales and per share results have interacted through...
NasdaqGS:FWRD
NasdaqGS:FWRDLogistics

Forward Air (FWRD) Q4 Loss Of US$28.3 Million Tests Bullish Margin Recovery Narratives

Forward Air (FWRD) just posted its FY 2025 fourth quarter results with revenue of US$631.2 million and a basic EPS loss of US$0.91, while trailing twelve month revenue stands at US$2.5 billion against a trailing EPS loss of US$3.51 and a net loss of US$107.8 million. Over recent quarters, the company has seen quarterly revenue hold in a tight range around US$613.3 million to US$655.9 million, while quarterly EPS losses have moved between US$0.41 and US$2.59. This gives investors a clear view...
NYSE:TFX
NYSE:TFXMedical Equipment

Assessing Teleflex (TFX) Valuation After Recent Share Price Momentum and Mixed Fair Value Signals

Teleflex stock performance and recent context Teleflex (TFX) has drawn fresh attention after recent price moves, with the stock last closing at $131.68. For investors, the key question is how current performance aligns with the underlying medical device business. See our latest analysis for Teleflex. The recent 6.9% 1 day share price return and 14.0% 30 day share price return indicate short term momentum is building, yet the 3 year total shareholder return of 45.9% decline highlights how far...
OTCPK:NLST
OTCPK:NLSTElectronic

A Look At Netlist’s (OTCPK:NLST) Valuation As Q1 2026 Earnings Approach

Upcoming earnings as the focus for Netlist (NLST) Netlist (NLST) is drawing attention after scheduling the release of its first quarter 2026 financial results before the market opens on May 12, followed by a same day earnings call. See our latest analysis for Netlist. The scheduled Q1 2026 results arrive after a period of strong momentum, with Netlist’s 30 day share price return of 81.08% and year to date share price return of 170.30%, even though the 3 year total shareholder return is a...
NasdaqGS:WBD
NasdaqGS:WBDEntertainment

Ted Turner’s Legacy Meets New Risks For Warner Bros Discovery Investors

Founder of CNN and early Turner Broadcasting leader Ted Turner has died, marking a major moment for Warner Bros. Discovery’s CNN franchise. The death comes as CNN’s domestic audience hits new lows and Warner Bros. Discovery’s linear TV segment faces ongoing financial pressure. At the same time, the planned Paramount and Skydance combination is moving forward, drawing heightened scrutiny of foreign ownership in US media assets. For investors watching NasdaqGS:WBD, this mix of legacy and...
NasdaqGM:URGN
NasdaqGM:URGNBiotechs

A Look At UroGen Pharma (URGN) Valuation After Strong Recent Share Price Momentum

What recent performance says about UroGen Pharma (URGN) Without a clear single event driving headlines, UroGen Pharma (URGN) has still drawn attention after a recent share price of US$26.59 and strong moves over the past month and past 3 months. See our latest analysis for UroGen Pharma. Those sharp recent share price returns, including a 47.48% 30 day share price return and 24.54% 90 day share price return, sit on top of a 149.20% 1 year total shareholder return. This indicates that momentum...